Tiptree Financial Inc. (NASDAQ:TIPT) (“Tiptree”) and Fortegra Financial
Corporation (“Fortegra”) announced today completion of the previously
announced merger of Fortegra into a subsidiary of Tiptree for
approximately $218 million in cash.
SOUTH SAN FRANCISCO, CA--(Marketwired - October 29, 2014) - A global leader and innovator of multi-screen video software worldwide, Envivio (NASDAQ: ENVI) today announced it will showcase its latest advancements in multi-screen, 4K and virtualized video processing, delivery and personalization for pay TV operators in the Middle East and North Africa (MENA) regions at TV Connect MENA 2014, Nov.
By Philip van Doorn, MarketWatch OPEC has started a price war by deciding not to cut oil production
The decision by OPEC on Thursday not to cut oil production, despite a price decline of over 30% since June, means U.S. shale-oil producers may soon find business to be unprofitable.
By Jeff Reeves, MarketWatch From Janet Yellen to black swans, investors should prepare
It is shaping up to be another great year for stocks, with the S&P 500 up about 12% year-to-date in 2014 after a roughly 30% gain in 2013.
plc (NYSE: MNK) has been informed by the U.S. Food and Drug
Administration (FDA) that the agency has reason to believe that the
company’s methylphenidate hydrochloride extended-release (ER) tablets,
USP (CII) may not be therapeutically equivalent to the category
reference drug Concerta®. As a result, the agency indicated that it has
reclassified Mallinckrodt’s ANDA 202608 for methylphenidate ER dosage
strengths of 27mg, 36 mg and 54 mg from AB (freely substitutable at the
pharmacy level) to BX (presumed to be therapeutically inequivalent). The
agency said that this change was based on the application of its new
Draft Guidance for determining bioequivalence of methylphenidate
hydrochloride products just published on November 6, 2014.
Vanguard Natural Resources, LLC (NASDAQ: VNR) (“Vanguard”) has declared
a cash distribution attributable to the month of October 2014 of $0.21
per unit ($2.52 on an annual basis) payable on December 15, 2014 to
unitholders of record on December 1, 2014.
Pro Forma Results: - Adjusted Net Income of $35.5 Million or $0.40 per Fully Diluted Share for the Third Quarter; $116.2 Million or $1.31 per Fully Diluted Share for the First Nine Months 2014
- Adjusted EBITDA of $57.8 Million for the Third Quarter; $193.7 Million for the First Nine Months 2014 Assets Under Administration of $212.8 Billion; up 11.3% From the Year Ago Period Following Review by Independent External Counsel and Forensic Accounting Firm, RCS Capital's Audit Committee and Management Team Remain Confident in The Company's Reported Historical Financials, Accounting, and Internal Controls $57 - $65 Million Revenue Synergies and Cost Savings Expected to be in Place for January 1, 2015; Additional Synergies Expected in 2015 9,139 Total Advisors on Platform; 97.8% Annualized Advisor Retention; Solid Retail Margin Expansion in Third Quarter; Robust Recruiting Pipeline Wholesale Distribution Equity Sales of $2.3 Billion for the Third Quarter; $8.2
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.